FAKTOR-OPTIONSSCHEIN - UCB | Market Closed - Deutsche Boerse AG 20:39:33 09/05/2024 BST | ||
| 1.94 EUR | +4.86% |
|
| Current month | +10.23% | ||
| 1 month | -9.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
UCB
Latest news about UCB
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/05/24 | 1.94 | +4.86% | 0 |
| 08/05/24 | 1.85 | -2.12% | 0 |
| 07/05/24 | 1.89 | -1.05% | 0 |
| 06/05/24 | 1.91 | +2.69% | 0 |
| 03/05/24 | 1.86 | +1.09% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 09, 2024 at 08:39 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | UCB |
| Issuer | 
Société Générale
|
| WKN | SR8VUC |
| ISIN | DE000SR8VUC1 |
| Date issued | 28/05/2020 |
| Strike | 82.97 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.23 € |
|---|---|
| Lowest since issue | 1.73 € |
| Spread | 0.02 € |
| Spread % | 1.02% |
Company Profile
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Sector
-
Consensus: UCB
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
118.8
EUR
Average target price
125.5
EUR
Spread / Average Target
+5.68%
- Stock Market
- Certificates
- Certificat
